Demetrios Kalaitzidis, Ph.D.
Affiliations: | 2006 | Boston University, Boston, MA, United States |
Area:
Molecular Biology, Cell BiologyGoogle:
"Demetrios Kalaitzidis"Parents
Sign in to add mentor| Thomas D. Gilmore | grad student | 2006 | Boston University | |
| (Characterization of the mis-regulated REL/NF -kappaB pathway in the RC -K8 human lymphoma cell line and characterization of a conditionally active REL -estrogen receptor fusion protein.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| McEwan B, Kuppuraju M, Padalia Z, et al. (2020) Abstract 880: Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro Immunology. 80: 880-880 |
| Padalia Z, Dunn A, Karagiannis K, et al. (2020) Abstract 879: Functional and single-cell assessment of CRISPR-modified CAR-T cells from NSCLC patients and healthy donors Immunology |
| McEwan B, Padalia Z, Porras A, et al. (2019) Abstract 1428: Allogeneic CRISPR/Cas9 gene-edited CAR-T cells targeting CD33 show potent preclinical activity against AML cells Cancer Research. 79: 1428-1428 |
| Dar H, Henderson D, Padalia Z, et al. (2018) Preclinical Development of CTX120, an Allogeneic CAR-T Cell Targeting Bcma Blood. 132: 1921-1921 |
| Padalia Z, Porras A, Dequeant ML, et al. (2018) Abstract 2551: Allogeneic CRISPR engineered anti CD70 CAR T cells demonstrate potent preclinical activity against both solid and hematological cancer cells Cancer Research. 78: 2551-2551 |
| Lee PY, Sykes DB, Ameri S, et al. (2017) The metabolic regulator mTORC1 controls terminal myeloid differentiation. Science Immunology. 2 |
| Kalaitzidis D, Lee D, Efeyan A, et al. (2017) Amino acid-insensitive mTORC1 regulation enables nutritional stress resilience in hematopoietic stem cells. The Journal of Clinical Investigation |
| Lee D, Wang YH, Kalaitzidis D, et al. (2016) Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy. The Journal of Clinical Investigation |
| Lee D, Sykes SM, Kalaitzidis D, et al. (2014) Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors. Stem Cell Reports. 3: 832-40 |
| Kalaitzidis D, Scadden DT. (2014) Deep diving in the blood stem cell-ome. The Embo Journal. 33: 2281-2 |